On 27 November 2024, the opinion on the major change was adopted by the BPC [Biocidal Products Committee (BPC) opinion of 27 November 2024 on the major change to the Union authorisation of the biocidal product family ‘HYPO-CHLOR Product Family’ (ECHA/BPC/452/2024), https://echa.europa.eu/de/opinions-on-union-authorisation.]. The opinion concludes that as the efficacy study provided was not performed with the product for which the change of the authorisation was sought, efficacy has not been proven for the duration of the product’s shelf life. The Agency therefore recommends not to amend the authorisation of ‘HYPO-CHLOR Product Family’ to include ‘meta SPC 1 HYPO-CHLOR 5,25 %’.
Recital 6, Decision_act (EU) 2025/2214
In forcesince 31 Oct 2025